Differential over‐expression of mdr1 genes in multidrug‐resistant rat glioblastoma cell lines selected with doxorubicin or vincristine
- 19 August 1993
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 55 (1) , 115-121
Abstract
We have compared the pharmacological and molecular characteristics of 2 cell lines derived from the C6 rat glioblastoma, and selected for resistance either to doxorubicin (C6 0.5 line) or to vincristine (C6 IV line). Each line displays a preferential 400‐fold resistance towards the drug used for selection, the C6 IV line being especially weakly resistant to doxorubicin (13‐fold). Verapamil completely restored doxorubicin sensitivity in the C6 IV line as well as vincristine resistance in the C6 0.5 line, but could not completely reverse doxorubicin resistance in the C6 0.5 line or vincristine resistance in the C6 IV line. This suggests that specific mechanisms of resistance against each drug were added to a common P‐glycoprotein‐mediated multi‐drug‐resistance mechanism. Doxorubicin efflux was total within 2 hr in the C6 IV line, whereas it remained 8 to 10% of drug in the C6 0.5 line 4 hr after drug removal, despite a more rapid efflux of the drug in the first 30 min. This 2‐compartment behavior could be related to a special sub‐cellular distribution of doxorubicin in C6 0.5 cells. Northern and Western blot analysis of the mdr I gene and of the P‐glycoprotein expressed by the 2 resistant cell lines made it possible to quantify their degree of over‐expression; when compared with the C6 wild strain, the C6 0.5 line over‐expressed both the mdr1 gene and the P‐glycoprotein to a slightly higher level than the C6 IV line. Northern and Western blot analysis also suggested that C6 0.5 cell preferentially over‐expressed the mdr I a gene, whereas the C6 IV cells preferentially over‐expressed the mdr Ib gene. This differential over‐expression was confirmed after polymerase‐chain‐reaction amplification of the cDNA sequences transcribed from total RNA extracted from the 2 lines. It can be concluded therefore that the mdr Ia gene product is more efficient than the mdr Ib gene product in extruding anti‐cancer drugs from the cells; and that the mdr Ib gene product might preferentially extrude vincristine rather than doxorubicin.Keywords
This publication has 22 references indexed in Scilit:
- Cloning and characterization of a member of the rat multidrug resistance (mdr) gene familyGene, 1991
- Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines in a model of doxorubicin-sensitive and -resistant rat glioblastoma cellsBiochemical Pharmacology, 1989
- Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine.Proceedings of the National Academy of Sciences, 1987
- Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistanceNature, 1986
- Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell, 1986
- Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteinsCell, 1986
- Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodiesNature, 1985
- A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blotsAnalytical Biochemistry, 1984
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Differentiated Rat Glial Cell Strain in Tissue CultureScience, 1968